AGAlfonso Gulias-Herrero

Alfonso Gulias-Herrero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alfonso Gulias-Herrero has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel Cuevas-Ramos

    Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico

    2 shared publications
  • Adrian Soto-Mota

    Metabolic Diseases Research Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    1 shared publication
  • Aldo A. Acosta-Medina

    Department of Internal Medicine, Mayo Clinic, Rochester, MN

    1 shared publication
  • Alfredo Ponce-De-León

    Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    1 shared publication
  • Alhely Gaytan-Santillan

    Department of Internal Medicine, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

    1 shared publication
  • Anaclara Michel-Chávez

    Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    1 shared publication

Latest Publications

  • Open Access

    Guiding Inpatient Glycemic Management with Continuous Glucose Monitoring. A Prospective Nonrandomized Comparative Cohort Study

    by Alhely Gaytan-Santillan, Adrian Soto-Mota, Daniel Cuevas-Ramos, Roopa Mehta, Alfonso Gulias-Herrero

  • Effect of Liposuction on Body Weight and Serum Concentrations of Leptin, Lipids, Glucose, and Insulin: A Meta-Analysis

    by Miguel Ángel Gómez-Sámano, Anna Paula Guerrero-Castillo, Jorge Antonio Abarca-Arroyo, Elena Cristina Albuja-González, Hans Alessandro García-Bonilla, Héctor Donaldo Espinosa-Salazar, María Teresa Villanueva-Gómez-Crespo, Andrés Catzin-Kuhlmann, Hugo López-Gatell, Cristina Aurora Tlapanco-Beltrán, et al.

    Background: Abdominal obesity has been associated with an increased risk of insulin resistance, metabolic syndrome, and diabetes. Central fat removal procedures such as liposuction, lipectomy, and abdominoplasty are among the most common surgical procedures. The impact of the latter on the former is controversial and understudied. The authors aimed to explore the effect of subcutaneous fat elimination procedures on insulin resistance measures and adipokine levels. Methods: Relevant studies regarding the effects of surgical subcutaneous fat removal on glucose, insulin, adipokines, and lipid metabolism, as well as blood pressure, were identified by searching PubMed and Ovid–Cochrane without limits in date, type of publication, or language. After the selection process, 24 studies were obtained. The results of the articles were summarized using descriptive statistics. For the final analysis, a randomized effects model was used to evaluate heterogeneity; averages and meta-analytic differences were expressed with a confidence interval of 95%. Results: All studies reported a reduction in weight (−2.64 kg; 95% CI, −4.32 to −0.96; P = 0.002; I2 = 36%; P of I2 < 0.001) and body mass index after liposuction. A significant improvement in triglycerides (−10.06 mg/dL; 95% CI, −14.03 to −6.09; P < 0.001; I2 = 48%; P of I2 = 0.05), serum glucose concentration (−4.25 mg/dL; 95% CI, −5.93 to −2.56; P < 0.001; I2 = 68%; P of I2 < 0.001), serum insulin concentration (−2.86 μIU/mL; 95% CI, −3.75 to −1.97; P < 0.001; I2 = 59%; P of I2 = 0.003), and serum leptin concentration (−7.70 ng/mL; 95% CI, −11.49 to −3.92; P = 0.0001; I2 = 96%; P of I2 < 0.001) was consistently observed. Conclusion: In addition to weight loss, there is a significant decrease in leptin, triglyceride, glucose, and insulin serum concentrations after liposuction, a fact that should be considered in future discussions.


  • Predictors of Mechanical Ventilation in Guillain–Barré Syndrome with Axonal Subtypes

    by Anaclara Michel-Chávez, Erwin Chiquete, Alfonso Gulías-Herrero, Diego Luis Carrillo-Pérez, Antonio Olivas-Martínez, Julio Macías-Gallardo, José de Jesús Aceves-Buendía, Eduardo Ruiz-Ruiz, Tatiana Bliskunova, Jennefer Portillo-Valle, et al.

    Background: The early clinical predictors of respiratory failure in Latin Americans with Guillain–Barré syndrome (GBS) have scarcely been studied. This is of particular importance since Latin America has a high frequency of axonal GBS variants that may imply a worse prognosis.Methods: We studied 86 Mexican patients with GBS admitted to theInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, a referral center of Mexico City, to describe predictors of invasive mechanical ventilation (IMV).Results: The median age was 40 years (interquartile range: 26–53.5), with 60.5% men (male-to-female ratio: 1.53). Most patients (65%) had an infectious antecedent (40.6% gastrointestinal). At admission, 38% of patients had a Medical Research Council (MRC) sum score <30. Axonal subtypes predominated (60.5%), with acute motor axonal neuropathy being the most prevalent (34.9%), followed by acute inflammatory demyelinating polyneuropathy (32.6%), acute motor sensory axonal neuropathy (AMSAN) (25.6%), and Fisher syndrome (7%). Notably, 15.1% had onset in upper limbs, 75.6% dysautonomia, and 73.3% pain. In all, 86% received either IVIg (9.3%) or plasma exchange (74.4%). IMV was required in 39.5% patients (72.7% in AMSAN). A multivariate model without including published prognostic scores yielded the time since onset to admission <15 days, axonal variants, MRC sum score 4, and dysautonomia as predictors.Conclusion: These results suggest that EGRIS is a good prognosticator of IMV in GBS patients with a predominance of axonal electrophysiological subtypes, but other early clinical data should also be considered.


  • Serum Uric Acid concentration is associated with insulin resistance and impaired insulin secretion in adults at risk for Type 2 Diabetes

    by Froylan D. Martínez-Sánchez, Valerie Paola Vargas-Abonce, Anna Paula Guerrero-Castillo, Manuel De Los Santos-Villavicencio, Jocelyn Eseiza-Acevedo, Clara Elena Meza-Arana, Alfonso Gulias-Herrero, Miguel Ángel Gómez-Sámano


  • Open Access

    Epicardial adipose tissue thickness is associated with increased COVID-19 severity and mortality

    by Roopa Mehta, Omar Yaxmehen Bello-Chavolla, Leonardo Mancillas-Adame, Marcela Rodriguez-Flores, Natalia Ramírez Pedraza, Bethsabel Rodríguez Encinas, Carolina Isabel Pérez Carrión, María Isabel Jasso Ávila, Jorge Carlos Valladares-García, Pablo Esteban Vanegas-Cedillo, et al.

    BACKGROUND Obesity, in particular, visceral adipose tissue has been linked to adverse COVID-19 outcomes. The amount of epicardial adipose tissue (EAT) may have relevant implications given its proximity to the heart and lungs. Here, we explored the role of EAT in increasing the risk for COVID-19 adverse outcomes. METHODS We included 748 patients with COVID-19 attending a reference centre in Mexico City. EAT thickness, sub-thoracic and pericardial fat were measured using thoracic CT scans. We explored the association of each thoracic adipose tissue compartment with critical COVID-19 and mortality according to the presence or absence of obesity. Mediation analyses evaluated the role of EAT in facilitating the effect of age, body mass index and cardiac troponin levels with adverse COVID-19 outcomes. RESULTS EAT thickness was associated with increased risk of COVID-19 mortality (HR 1.18, 95%CI 1.01-1.39) independent of age, gender, comorbid conditions and BMI. Increased EAT was associated with lower SpO2 and PaFi index and higher levels of cardiac troponins, D-dimer, C-reactive protein, and 4C severity score, independent of obesity. EAT mediated 13.1% (95%CI 3.67-28.0%) and 5.1% (95%CI 0.19-14.0%) of the effect of age and 19.4% (95%CI 4.67-63.0%) and 12.8% (95%CI 0.03-46.0%) of the effect of BMI on requirement for intubation and mortality, respectively. EAT also mediated the effect of increased cardiac troponins on myocardial infarction during COVID-19. CONCLUSION EAT is an independent risk factor for severe COVID-19 and mortality independent of obesity. EAT partly mediates the effect of age and BMI and increased cardiac troponins on adverse COVID-19 outcomes.


  • Open Access

    Outcomes and Challenges of Reproductive Health in Hematopoietic Stem Cell Transplantation Survivors

    by Christianne Bourlon, Santiago Riviello-Goya, Aldo A Acosta-Medina, Rosa E. Caballero-Landinez, Angelica Manrique-Rubio, Kevin Teran-De-La-Sancha, Alfonso Gulias-Herrero, Maria T. Bourlon